Small Pharma raises £830,000 from angel investors

April 7, 2017

A firm which is developing a drug for patients experiencing severe depression using a derivative of horse tranquiliser ketamine has raised £830,000 from noted pharma sector investors and via an angel investing platform.

Small Pharma, a London-based pharmaceutical start-up, said the funds raised will be supplemented by a £140,000 grant from Innovate UK to support the development of a rapid-acting drug.

The funding round was led by Chris Torrance, co-founder of AIM-listed Horizon Discovery Group PLC(LON:HZD) and PhoreMost, with the Angel Co-Fund, pharma sector experts and investors Steve Harris, David Ebsworth and Peter Keen, and Secret Escapes co-founder, Tom Valentine, also participating.

See the full article on Proactive Investors here

What rights will the Angel CoFund have in investment documentation?
Read FAQs

Investment Team

Meet the team

We’re pretty sparing with our email comms, but when there are interesting and relevant things happening it’s great to share. If you’d like to receive updates and hear more about what is happening with ACF Investors and the portfolio then please sign up here.

Website by James Dowen Web Designer Web Developer Web design london